Skip to main content
. 2020 Jun 3;9(6):1727. doi: 10.3390/jcm9061727

Figure 2.

Figure 2

ROC and AUC for bilirubin on day 5 of ECLS therapy as a discriminator for mortality, excluding shock liver patients (n = 220). AUC = 0.67 (95% confidence interval (CI): 0.59–0.75).